Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
14,210,499
-
Shares change
-
+1,783,553
-
Total reported value, excl. options
-
$591,072,741
-
Value change
-
+$80,484,868
-
Put/Call ratio
-
7.23%
-
Number of buys
-
35
-
Number of sells
-
-30
-
Price
-
$41.59
Significant Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q3 2021
79 filings reported holding BCYC - BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") as of Q3 2021.
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,210,499 shares
of 22,866,677 outstanding shares and own 62.15% of the company stock.
Largest 10 shareholders include TYBOURNE CAPITAL MANAGEMENT (HK) LTD (1,957,961 shares), JANUS HENDERSON GROUP PLC (1,743,005 shares), Point72 Asset Management, L.P. (1,615,092 shares), Logos Global Management LP (1,475,000 shares), SV Health Investors, LLC (1,436,456 shares), EVENTIDE ASSET MANAGEMENT, LLC (1,163,471 shares), First Light Asset Management, LLC (732,731 shares), Ikarian Capital, LLC (526,500 shares), FMR LLC (461,629 shares), and SAMLYN CAPITAL, LLC (454,881 shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.